About Genuity Science
Genuity Science is a company based in Boston (United States) founded in 2013 by Jeff Gulcher was acquired by Hibercell in August 2021. Genuity Science has raised $515 million across 3 funding rounds from investors including Temasek, HiberCell and Ireland Strategic Investment Fund. Genuity Science has completed 1 acquisition, including Genomics Medicine Ireland. Genuity Science offers products and services including Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery. Genuity Science operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
- Headquarter Boston, United States
- Founders Jeff Gulcher
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genuity Science
Genuity Science offers a comprehensive portfolio of products and services, including Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery.
Identifies novel targets using genetic evidence for drug development research.
Validates targets and biomarkers to optimize research investments effectively.
Designs studies by identifying sub-populations for better trial outcomes.
Discovers biomarkers for disease stratification and targeted therapies.
People of Genuity Science
Unlock access to complete
Unlock access to complete
Funding Insights of Genuity Science
Genuity Science has successfully raised a total of $515M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $200 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genuity Science
Genuity Science has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Temasek, HiberCell and Ireland Strategic Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Genuity Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genuity Science
Genuity Science has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genomics Medicine Ireland.
Investment portfolio details for Genuity Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Population genomics database for disease risk analysis is developed.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Genuity Science
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Genuity Science
Detailed financials for Genuity Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genuity Science Comparisons
Peer comparison for Genuity Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genuity Science
Genuity Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Biosimulation platform developed for therapeutic design in life sciences.
|
Detailed competitors of Genuity Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genuity Science
Complete news archive for Genuity Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genuity Science
Genuity Science was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Genuity Science is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Rob Brainin is the current CEO of Genuity Science.
Genuity Science is a funded company, having raised a total of $515M across 3 funding rounds to date.
Founded in 2013 and based in Boston, United States, Genuity Science operates in the biotechnology sector. Omics data, including genomic and phenotypic information, is analyzed through AI-driven tools. These solutions support drug discovery, design, and development, as well as clinical trial studies and broader genomic research. Services are tailored for researchers seeking efficient data interpretation in scientific applications.
Genuity Science's top competitors include Helix, Benchling and BioAge Labs.
Genuity Science offers Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery.
Genuity Science has made 1 acquisition, including Genomics Medicine Ireland.
Genuity Science has 7 investors. Key investors include Temasek, HiberCell, Ireland Strategic Investment Fund, Yunfeng Capital, and Sequoia Capital.